• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Licensing deals

Closeup of blue eye on black background
Biotech

AviadoBio secures option to rare eye disease gene therapy

England's AviadoBio is looking to China as a potential source of additional gene therapies.
James Waldron Oct 9, 2025 8:50am
Two businessmen pushing giant puzzle pieces together as the sun sets behind them

CDMO Catalent strengthens ADC pipeline with $10M Lisata pact

Oct 9, 2025 7:45am
Tiny green sprout growing from soil

Chiesi fertilizes Arbor's gene therapy with $2B biobucks deal

Oct 6, 2025 7:00am
100 dollar bills scattered in the air money inflation concept

AbbVie flags $2.7B R&D hit to brace investors for lower profit

Oct 6, 2025 3:27am
A ballpoint pen rests on top of a stack of documents ready for signing

Kyorin pens $105M pact for Japan rights to Hinge's lupus drug

Oct 1, 2025 6:40am
A close-up view of a jigsaw puzzle with a missing piece

Novo Holdings-backed biotech raises $205M to fill gout care gap

Sep 30, 2025 8:00am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings